Compare AdaptHealth Corp (AHCO) vs ThredUp Inc (TDUP) Price & Performance

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

TDUP trades at $6.84, down 2.7% today, with a consensus price target of $6.90. The stock shows bullish technical signals from moving averages, though oscillators are neutral. Recent Q1 2026 results met EPS expectations with record active buyers and 15% revenue growth. The company maintains a high gross margin of 79.4% but continues to report net losses, with improving cash flow from operations turning positive in 2025.

Investment outlook remains cautiously optimistic given analyst consensus (57% buy ratings) and recent business initiatives including AI integration and marketplace expansion. Key risks include persistent unprofitability and competitive pressures in resale markets. The stock presents potential for growth if margin improvements continue, but requires monitoring of earnings trajectory.